ClinConnect ClinConnect Logo
Search / Trial NCT06806748

Gait Recovery After Stroke

Launched by UNIVERSITY OF STRATHCLYDE · Jan 28, 2025

Trial Information

Current as of August 21, 2025

Not yet recruiting

Keywords

Observational, Gait, Symmetry

ClinConnect Summary

The "Gait Recovery After Stroke" trial is studying how people recover their walking balance and stability after having a stroke. Researchers will use special wearable sensors to measure how well participants can stand evenly on both legs during the first six months after their stroke. They also want to understand how different factors, like the type of stroke and which side of the body is affected, impact this recovery process.

To join this study, participants need to be at least 18 years old and have experienced their first stroke, confirmed by a stroke specialist. They should also be stable enough to participate in rehabilitation and able to walk with some assistance. However, individuals with certain conditions, like severe skin issues, previous mild strokes, or diseases that affect walking, will not be eligible. While the trial is not recruiting yet, those who participate can expect to wear sensors that help track their progress as they work on their walking abilities. This research aims to improve understanding of stroke recovery and help develop better rehabilitation strategies.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • aged 18 or older
  • diagnosis of a first occurrence of stroke by consultant stroke physician
  • Medically stable
  • referred for rehabilitation
  • functional ambulatory category of 1 and over
  • Exclusion Criteria:
  • acute skin condition
  • transient ischemic stroke
  • comorbidities that may interfere with walking function, such as Parkinson's disease or lower limb amputation
  • severe communication impairments or delirium

About University Of Strathclyde

The University of Strathclyde is a leading research institution based in Glasgow, Scotland, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its robust academic resources and interdisciplinary expertise to drive impactful research initiatives. With a focus on improving patient outcomes and fostering collaboration between academia and industry, the University of Strathclyde is dedicated to conducting high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately contributing to the advancement of medical science and public health.

Locations

Patients applied

0 patients applied

Trial Officials

Andrew Kerr, Ph.D

Principal Investigator

University of Strathclyde

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported